AcquisitionOther

Avere Therapeutics (via merger) acquired NextCure, Inc.

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Avere Therapeutics (via merger) -> NextCure, Inc. · $320 million

Combine Avere's differentiated oral IL-23 program with NextCure's public market infrastructure.

Open source record (SEC) ↗

Have a question, or want to talk something through?

Let's Talk